We are a leading pharmaceutical supply chain solution provider in China, and ranked second in the PRC pharmaceutical distribution business in terms of scale in 2015. Leveraging our comprehensive product offerings, wide distribution networks and strength in high-end pharmaceutical products, we directly distribute products to hospitals and other medical institutions in 31 provinces in China. We also established long-term stable cooperative relationships with nearly 10,000 upstream suppliers. Our retail pharmacy network of more than 700 retail pharmacies include a number of national and regional premium brand names such as "CR Care (???)," "Yibaoquanxin (????)," "Li'an chain (????)," and "Tung Tak Tong (???)." We have enriched and high-quality resources and outstanding capabilities in research and development. We conduct our independent research and development activities through the Pharmaceutical R&D Center and our subsidiaries, which administer the National Research Center for Gelatin Traditional Chinese Medicine Engineering and Technology (??????????????) and the National Research Center for Proprietary Chinese Medicine Engineering and Technology (?????????????) . We also collaborate with external research partners, including leading research institutions such as the Institute of Biophysics of the Chinese Academy of Science (????????????) , the National Center for Nanoscience and Technology (????????), leading universities and hospitals includes Institute of Material Medical, Chinese Academy of Medical Sciences, Peking University and Shenyang Pharmaceutical University, as well as medical research institutes in the United States and Korea. We have 20 R&D projects were listed in National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the Eleventh and Twelfth Five-year Plan Period and have nearly 1,000 patents. Adhering to our mission "be the guardian of human health and improve quality of life", we will continue to expand our business in major stages of our ...
View Top Employees from 华润生物医药(深圳)有限公司Website | https://www.crpharm.com |
Revenue | $31.6 billion |
Employees | 11 (3 on RocketReach) |
Founded | 2007 |
Address | China Resources Building 4101-05 Harbour Rd 41/f 26, Hong Kong, Guangdong, CN |
Phone | +86 755 8336 0999 |
Fax | +852 2593 8992 |
Industry | Manufacturing, Pharmaceutical Manufacturing, Manufacturing General, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | 冠爽, 华润医药, 河南华润医药有限公司, 华润医药校招, 郭键勋 华润 |
Competitors | Daiichi Sankyo Inc, Mylan Belgium, Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm, Teva Pharmaceuticals UK |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 4242 Companies, NAICS Code 621 Companies, NAICS Code 6215 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 424 Companies, NAICS Code 62 Companies, NAICS Code 42 Companies, NAICS Code 42421 Companies, NAICS Code 62151 Companies |
Looking for a particular 华润生物医药(深圳)有限公司 employee's phone or email?
The 华润生物医药(深圳)有限公司 annual revenue was $31.6 billion in 2023.
3 people are employed at 华润生物医药(深圳)有限公司.
华润生物医药(深圳)有限公司 is based in Hong Kong, Guangdong.
The NAICS codes for 华润生物医药(深圳)有限公司 are [4242, 621, 6215, 325, 32, 424, 62, 42, 42421, 62151].
The SIC codes for 华润生物医药(深圳)有限公司 are [28, 283].